BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27977806)

  • 1. Integrated Activity and Genetic Profiling of Secreted Peptidases in Cryptococcus neoformans Reveals an Aspartyl Peptidase Required for Low pH Survival and Virulence.
    Clarke SC; Dumesic PA; Homer CM; O'Donoghue AJ; La Greca F; Pallova L; Majer P; Madhani HD; Craik CS
    PLoS Pathog; 2016 Dec; 12(12):e1006051. PubMed ID: 27977806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspartyl peptidase May1 induces host inflammatory response by altering cell wall composition in the fungal pathogen
    Li Y; Chadwick B; Pham T; Xie X; Lin X
    mBio; 2024 Jun; 15(6):e0092024. PubMed ID: 38742885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-emerging Aspartic Protease Targets: Examining
    Kryštůfek R; Šácha P; Starková J; Brynda J; Hradilek M; Tloušt'ová E; Grzymska J; Rut W; Boucher MJ; Drąg M; Majer P; Hájek M; Řezáčová P; Madhani HD; Craik CS; Konvalinka J
    J Med Chem; 2021 May; 64(10):6706-6719. PubMed ID: 34006103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease.
    Vu K; Tham R; Uhrig JP; Thompson GR; Na Pombejra S; Jamklang M; Bautos JM; Gelli A
    mBio; 2014 Jun; 5(3):e01101-14. PubMed ID: 24895304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Aph1, a phosphate-regulated, secreted, and vacuolar acid phosphatase in Cryptococcus neoformans.
    Lev S; Crossett B; Cha SY; Desmarini D; Li C; Chayakulkeeree M; Wilson CF; Williamson PR; Sorrell TC; Djordjevic JT
    mBio; 2014 Sep; 5(5):e01649-14. PubMed ID: 25227465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcus neoformans Cda1 and Its Chitin Deacetylase Activity Are Required for Fungal Pathogenesis.
    Upadhya R; Baker LG; Lam WC; Specht CA; Donlin MJ; Lodge JK
    mBio; 2018 Nov; 9(6):. PubMed ID: 30459196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arg1 from
    Desmarini D; Liu G; Jessen H; Bowring B; Connolly A; Crossett B; Djordjevic JT
    mBio; 2024 Jun; 15(6):e0060824. PubMed ID: 38742909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Ceramide Synthases in the Pathogenicity of Cryptococcus neoformans.
    Munshi MA; Gardin JM; Singh A; Luberto C; Rieger R; Bouklas T; Fries BC; Del Poeta M
    Cell Rep; 2018 Feb; 22(6):1392-1400. PubMed ID: 29425496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CTR4 in the Virulence of Cryptococcus neoformans.
    Waterman SR; Park YD; Raja M; Qiu J; Hammoud DA; O'Halloran TV; Williamson PR
    mBio; 2012; 3(5):. PubMed ID: 23033470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino Acid Permeases and Virulence in Cryptococcus neoformans.
    Martho KF; de Melo AT; Takahashi JP; Guerra JM; Santos DC; Purisco SU; Melhem MS; Fazioli RD; Phanord C; Sartorelli P; Vallim MA; Pascon RC
    PLoS One; 2016; 11(10):e0163919. PubMed ID: 27695080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Monothiol Glutaredoxin Grx4 Regulates Iron Homeostasis and Virulence in Cryptococcus neoformans.
    Attarian R; Hu G; Sánchez-León E; Caza M; Croll D; Do E; Bach H; Missall T; Lodge J; Jung WH; Kronstad JW
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward an integrated model of capsule regulation in Cryptococcus neoformans.
    Haynes BC; Skowyra ML; Spencer SJ; Gish SR; Williams M; Held EP; Brent MR; Doering TL
    PLoS Pathog; 2011 Dec; 7(12):e1002411. PubMed ID: 22174677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome and secretome profiling of zinc availability in Cryptococcus neoformans identifies Wos2 as a subtle influencer of fungal virulence determinants.
    Ball B; Woroszchuk E; Sukumaran A; West H; Afaq A; Carruthers-Lay D; Muselius B; Gee L; Langille M; Pladwig S; Kazi S; Hendriks A; Geddes-McAlister J
    BMC Microbiol; 2021 Dec; 21(1):341. PubMed ID: 34903172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors required for activation of urease as a virulence determinant in Cryptococcus neoformans.
    Singh A; Panting RJ; Varma A; Saijo T; Waldron KJ; Jong A; Ngamskulrungroj P; Chang YC; Rutherford JC; Kwon-Chung KJ
    mBio; 2013 May; 4(3):e00220-13. PubMed ID: 23653445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics of
    Muselius B; Durand SL; Geddes-McAlister J
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cys
    Fan CL; Han LT; Jiang ST; Chang AN; Zhou ZY; Liu TB
    Fungal Genet Biol; 2019 Mar; 124():59-72. PubMed ID: 30630094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Small Protein Associated with Fungal Energy Metabolism Affects the Virulence of Cryptococcus neoformans in Mammals.
    McClelland EE; Ramagopal UA; Rivera J; Cox J; Nakouzi A; Prabu MM; Almo SC; Casadevall A
    PLoS Pathog; 2016 Sep; 12(9):e1005849. PubMed ID: 27583447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretome profiling of Cryptococcus neoformans reveals regulation of a subset of virulence-associated proteins and potential biomarkers by protein kinase A.
    Geddes JM; Croll D; Caza M; Stoynov N; Foster LJ; Kronstad JW
    BMC Microbiol; 2015 Oct; 15():206. PubMed ID: 26453029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defects in phosphate acquisition and storage influence virulence of Cryptococcus neoformans.
    Kretschmer M; Reiner E; Hu G; Tam N; Oliveira DL; Caza M; Yeon JH; Kim J; Kastrup CJ; Jung WH; Kronstad JW
    Infect Immun; 2014 Jul; 82(7):2697-712. PubMed ID: 24711572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic characterization of clinical and environmental Cryptococcus neoformans strains isolated in Italy.
    Pini G; Faggi E; Campisi E
    Rev Iberoam Micol; 2017; 34(2):77-82. PubMed ID: 28215482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.